Infectious Diseases Physician Workforce in Korea-Reference-Cited by-同舟云学术

Infectious Diseases Physician Workforce in Korea

Published:2020 Issue:49 Volume:35 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Jang Youngeun¹^ORCID,Park Se Yoon¹^ORCID,Kim Bongyoung²^ORCID,Lee Eunjung¹^ORCID,Lee Seungjae¹^ORCID,Son Hyo-Ju¹^ORCID,Park Jung Wan³^ORCID,Yu Shi Nae³^ORCID,Kim Tark⁴^ORCID,Jeon Min Hyok³^ORCID,Choo Eun Ju⁴^ORCID,Kim Tae Hyong¹^ORCID

Affiliation:

1. Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.

2. Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

3. Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.

4. Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.

Funder

National Research Foundation of Korea

Soonchunhyang University

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2020.35.e428

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shortage and unequal distribution of infectious disease specialists in Japan: How can we refine the current situation?;PLOS ONE;2023-10-20

2. Guidelines for Infection and Burnout Prevention in COVID-19 Healthcare Workers;Korean Journal of Healthcare-Associated Infection Control and Prevention;2023-06-30

3. Guidelines for Infection Control and Burnout Prevention in Healthcare Workers Responding to COVID-19;Infection & Chemotherapy;2023

4. Letter to the Editor: A Need for Infectious Disease Specialists in Public Healthcare Centers?;Journal of Korean Medical Science;2023

5. Change in the Perception of Oral Antibiotics Among Medical Students After Participating in a Parenteral-to-Oral Conversion Program for Highly Bioavailable Antibiotics;Open Forum Infectious Diseases;2022-10-11